218 related articles for article (PubMed ID: 30794626)
1. Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation.
Imai Y; Yoshida O; Watanabe T; Yukimoto A; Koizumi Y; Ikeda Y; Tokumoto Y; Hirooka M; Abe M; Hiasa Y
PLoS One; 2019; 14(2):e0212589. PubMed ID: 30794626
[TBL] [Abstract][Full Text] [Related]
2. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
[TBL] [Abstract][Full Text] [Related]
3. Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling.
Han S; Han L; Yao Y; Sun H; Zan X; Liu Q
Oncol Rep; 2014 Feb; 31(2):641-8. PubMed ID: 24284889
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production.
Myojin Y; Hikita H; Sugiyama M; Sasaki Y; Fukumoto K; Sakane S; Makino Y; Takemura N; Yamada R; Shigekawa M; Kodama T; Sakamori R; Kobayashi S; Tatsumi T; Suemizu H; Eguchi H; Kokudo N; Mizokami M; Takehara T
Gastroenterology; 2021 Apr; 160(5):1741-1754.e16. PubMed ID: 33346004
[TBL] [Abstract][Full Text] [Related]
5. CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.
Li ZQ; Wu WR; Zhao C; Zhao C; Zhang XL; Yang Z; Pan J; Si WK
Int J Mol Med; 2018 Mar; 41(3):1518-1528. PubMed ID: 29286082
[TBL] [Abstract][Full Text] [Related]
6. Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2.
Xu Y; Zhao W; Xu J; Li J; Hong Z; Yin Z; Wang X
Oncotarget; 2016 Feb; 7(8):8866-78. PubMed ID: 26758420
[TBL] [Abstract][Full Text] [Related]
7. Activation of human hepatic stellate cells enhances the metastatic ability of hepatocellular carcinoma cells via up-regulation of interleukin-1β.
Cheng B; Huang Z; Wu L; Lin Y; Lin W; Zhu Q
J BUON; 2021; 26(2):435-443. PubMed ID: 34076990
[TBL] [Abstract][Full Text] [Related]
8. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
[TBL] [Abstract][Full Text] [Related]
9. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
[TBL] [Abstract][Full Text] [Related]
10. Activated human hepatic stellate cells promote growth of human hepatocellular carcinoma in a subcutaneous xenograft nude mouse model.
Geng ZM; Li QH; Li WZ; Zheng JB; Shah V
Cell Biochem Biophys; 2014 Sep; 70(1):337-47. PubMed ID: 24676678
[TBL] [Abstract][Full Text] [Related]
11. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
[TBL] [Abstract][Full Text] [Related]
12. CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression.
Makino Y; Hikita H; Kodama T; Shigekawa M; Yamada R; Sakamori R; Eguchi H; Morii E; Yokoi H; Mukoyama M; Hiroshi S; Tatsumi T; Takehara T
Cancer Res; 2018 Sep; 78(17):4902-4914. PubMed ID: 29967264
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop.
Lin XH; Liu HH; Hsu SJ; Zhang R; Chen J; Chen J; Gao DM; Cui JF; Ren ZG; Chen RX
J Exp Clin Cancer Res; 2020 Apr; 39(1):64. PubMed ID: 32293507
[TBL] [Abstract][Full Text] [Related]
14. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
15. Cluster of differentiation 147 is a key molecule during hepatocellular carcinoma cell-hepatic stellate cell cross-talk in the rat liver.
Ma T; Wang Z; Yang Z; Chen J
Mol Med Rep; 2015 Jul; 12(1):111-8. PubMed ID: 25738354
[TBL] [Abstract][Full Text] [Related]
16. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway.
Xia Y; Zhen L; Li H; Wang S; Chen S; Wang C; Yang X
Cell Death Dis; 2021 Mar; 12(4):326. PubMed ID: 33771969
[TBL] [Abstract][Full Text] [Related]
17. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
[TBL] [Abstract][Full Text] [Related]
18. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.
Mikuriya Y; Tashiro H; Kuroda S; Nambu J; Kobayashi T; Amano H; Tanaka Y; Ohdan H
Int J Cancer; 2015 Feb; 136(4):E3-13. PubMed ID: 25053237
[TBL] [Abstract][Full Text] [Related]
19. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Xie YX; Liao R; Pan L; Du CY
Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase R modulates c-Fos and c-Jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis C virus infection.
Watanabe T; Hiasa Y; Tokumoto Y; Hirooka M; Abe M; Ikeda Y; Matsuura B; Chung RT; Onji M
PLoS One; 2013; 8(7):e67750. PubMed ID: 23844083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
